Bio & Healthcare Tech Investments & Thesis | a16z (2024)

Founders
with Vision
to Shape the
Future of Health,
We See You.

Our founders are building beyond the pre-defined edges of human health. Through the convergence of AI, technology, and biology, and the reimagining of healthcare, we’re the first call for bold entrepreneurs pushing boundaries and leading the way towards better care for all.

From life sciences to care delivery, spanning seed financing through IPO, we’re partnering with a new generation of determined, multidisciplinary entrepreneurs across the entire company‑building journey. Together we are building iconic companies that are radically transforming how we diagnose, treat, and manage disease, while building the healthcare system of tomorrow–a system of Enduring Health (™). Together, we are building the future. The Future is Health.

Bio Builders START YOUR JOURNEY HERE
Health Builders START YOUR JOURNEY HERE

Themes in Bio+Health

PODCASTRaising Health™ Our top-ranked podcast exploring the real challenges and enormous opportunities facing entrepreneurs who are building the future of health.
FEATURED ARTICLEHealthcare Marketplaces, Where Art Thou? We love marketplaces. Why are there so few in healthcare?
THESIS AREABuilding in Bio A new generation of founders is building a new generation of bio companies.
THESIS AREABuilding in Healthcare Software, finally, is eating healthcare.
FEATURED ARTICLEDoing More with Moore Science-native SaaS tools are modernizing how medicines are discovered, developed, and distributed.
FEATURED ARTICLEAI at the Intersection: The a16z Investment Thesis on AI in Bio + Health
THESIS AREAAI in Bio + Health A universe of new therapies, next-gen diagnostics, and provider tools is on the horizon.
SPECIAL FEATUREThe Opportunity for Healthcare x Fintech How technology will make our healthcare system more intuitive, efficient, and cost-effective.
SPECIAL FEATUREDigital Health Builders Playbooks for going to market in digital health.
FEATURED ARTICLEThe Biggest Company in the World Will the biggest company be a consumer healthtech company?
  • Behind the Buy: Payors and Providers on AI Adoption New

    Julie Yoo, Jay Rughani, Kris Tatiossian, and Olivia Webb

    This episode features interviews with payor and provider leaders about what they’re seeing and how they’re thinking about AI. Guided by Julie Yoo, general partner, and Jay Rughani, investment partner at a16z Bio + Health, you'll hear from the executives about how they're utilizing AI, the KPIs they use to gauge effectiveness, and what they consider to be a good partnership.

  • Biotech Revolution with Software Engineering Daily

    Sean Falconer, Vijay Pande, Kris Tatiossian, and Olivia Webb

    Vijay Pande, founding general partner at a16z Bio + Health, joins the Software Engineering Daily podcast to talk about innovation in biotech and healthcare, the biotech startup landscape, the impact of AI, and much more.

  • Dark Genome Hunting with Rosana Kapeller and Marty Taylor

    Vineeta Agarwala, Bryan Faust, Rosana Kapeller, Kris Tatiossian, Marty Taylor, and Olivia Webb

    Rosana Kapeller, CEO of Rome Therapeutics, and Marty Taylor, physician-scientist at Harvard Medical School, join Vineeta Agarwala, general partner, and Bryan Faust, investment partner at a16z Bio + Health.

  • DNA as Data Storage with Vijay Pande

    Vijay Pande, Stephanie Smith, Kris Tatiossian, and Olivia Webb

    Vijay Pande, founding partner of a16z Bio + Health, dives deep with a16z Podcast host Steph Smith into the potential of DNA as a data storage mechanism.

  • The Most Interesting Healthcare Companies You’ve Never Heard Of with Julie Klapstein

    Julie Klapstein, Kris Tatiossian, Olivia Webb, and Julie Yoo

    Julie Klapstein, founding CEO of Availity, long-time healthcare executive, and a16z Bio + Health's newest advisory partner, joins Julie Yoo, general partner at a16z Bio + Health.

Load More

Bio & Healthcare Tech Investments & Thesis | a16z (15) Bio & Healthcare Tech Investments & Thesis | a16z (16) Bio & Healthcare Tech Investments & Thesis | a16z (17)

Bio Eats World is
now Raising Health

AI, science, and technology experts explore the real challenges and enormous opportunities facing entrepreneurs who are building the future of health. Raising Health dives deep into the heart of biotechnology and healthcare innovation. Join veteran company builders Vijay Pande, Julie Yoo, Vineeta Agarwala, and Jorge Conde, and co-hosts Kris Tatiossian and Olivia Webb, on this journey.

LISTEN NOW

Bio+Health Portfolio

Bio & Healthcare Tech Investments & Thesis | a16z (18)

Investing in Tome Biosciences

Jorge Conde LEARN MORE

Bio & Healthcare Tech Investments & Thesis | a16z (19)

Bio & Healthcare Tech Investments & Thesis | a16z (20)

Investing in Function Oncology

Vineeta Agarwala LEARN MORE

Bio & Healthcare Tech Investments & Thesis | a16z (21)

Bio & Healthcare Tech Investments & Thesis | a16z (22)

Investing In Marker Learning

Julie Yoo LEARN MORE

Bio & Healthcare Tech Investments & Thesis | a16z (23)

Bio & Healthcare Tech Investments & Thesis | a16z (24)

Investing In IDRx

Jorge Conde LEARN MORE

Bio & Healthcare Tech Investments & Thesis | a16z (25)

Bio & Healthcare Tech Investments & Thesis | a16z (26)

Investing in Cartography

Jorge Conde LEARN MORE

Bio & Healthcare Tech Investments & Thesis | a16z (27)

Bio & Healthcare Tech Investments & Thesis | a16z (28)

Investing in SciFi Foods

Vijay Pande LEARN MORE

Bio & Healthcare Tech Investments & Thesis | a16z (29)

Bio & Healthcare Tech Investments & Thesis | a16z (30)

Investing in Season Health

Julie Yoo LEARN MORE

Bio & Healthcare Tech Investments & Thesis | a16z (31)

Bio & Healthcare Tech Investments & Thesis | a16z (34)

Investing In Waymark

Vineeta Agarwala LEARN MORE

Bio & Healthcare Tech Investments & Thesis | a16z (35)

Bio & Healthcare Tech Investments & Thesis | a16z (36)

Investing in Turquoise

Julie Yoo LEARN MORE

Bio & Healthcare Tech Investments & Thesis | a16z (37)

Bio & Healthcare Tech Investments & Thesis | a16z (38)

Investing in Hippocratic AI

Julie Yoo LEARN MORE

Bio & Healthcare Tech Investments & Thesis | a16z (39)

Bio & Healthcare Tech Investments & Thesis | a16z (40)

Investing in Pomelo Care

Vineeta Agarwala LEARN MORE

Bio & Healthcare Tech Investments & Thesis | a16z (41)

FOCUS AREA

  • All
  • Bio
  • Health

stage at initial investment

  • All
  • Seed
  • Venture
  • Growth

PORTFOLIO JOBS BOARD

  • Accolade Exit

  • AKASA

  • Amber

  • Ambience Healthcare

  • Apeel Sciences

  • Arda Therapeutics

  • Asimov

  • Bayesian Health

  • Benchling

  • BigHat Biosciences

  • BioAge Labs

  • Biodock

  • Bold

  • CAMP4 Therapeutics

  • Cardiogram Exit

  • Cartography Biosciences

  • Cedar

  • Ciitizen Exit

  • Deepcell

  • Devoted Health

  • Dyno Therapeutics

  • Earli

  • Elegen

  • EQRx Exit

  • Erasca Exit

  • Fidocure

  • Firefly Health

  • Fortuna Health

  • Freenome

  • Function Oncology

  • Gate Bio

  • Genesis Therapeutics

  • Headway

  • Hippocratic AI

  • Honor

  • IDRx

  • Inceptive

  • Incredible Health

  • Inductive Bio

  • Jungla Exit

  • Juniper Behavioral Health

  • Knownwell

  • Komodo Health

  • Levels Health

  • Mana Bio

  • Marker Learning

  • Marley Medical

  • Maze Therapeutics

  • Memora Health

  • Milu Health

  • Nautilus Biotechnology Exit

  • Nobell Foods

  • Octant Bio

  • Omada Health

  • Orbital Therapeutics

  • Orchestra Bio

  • Patch Biosciences Exit

  • PatientPing Exit

  • Patina

  • Pearl Health

  • Pine Medical

  • Pomelo Care

  • Propel

  • Q Bio

  • Rezo Therapeutics

  • Ribbon Health

  • Rigetti Exit

  • ROME Therapeutics

  • SCiFi Foods

  • Scribe Therapeutics

  • Season Health

  • Siduma

  • Sprinter Health

  • Thatch Health

  • Thyme Care

  • Tmunity Therapeutics Exit

  • Tome Bio

  • Tomorrow Health

  • Topography Health

  • Turquoise Health

  • Ultima Genomics

  • Valar Labs

  • Ventus Therapeutics

  • Vicinitas Therapeutics

  • Waymark

  • Zus Health

Any investments or portfolio companies mentioned, referred to, or described on this page are not representative of all investments in vehicles managed by a16z and there can be no assurance that the investments will be profitable or that other investments made in the future will have similar characteristics or results. Exits include current and former a16z portfolio companies which have been acquired as well as companies which have undergone an initial public offering or direct public offering of shares. Certain publicly traded companies on this list may still be held in Andreessen Horowitz funds. A list of investments made by funds managed by a16z is available here: https://a16z.com/investments/. Excluded from this list are investments for which the issuer has not provided permission for a16z to disclose publicly as well as unannounced investments in publicly traded digital assets. Further, the list of investments is updated monthly and as such may not reflect most recent a16z investments. Past results of Andreessen Horowitz’s investments, pooled investment vehicles, or investment strategies are not necessarily indicative of future results.

Bio & Healthcare Tech Investments & Thesis | a16z (42)

Andreessen Horowitz
x Bassett Healthcare

Catalysts. Conveners. Connective Tissue. Bringing tech-enabled innovations to patients through ecosystem partnerships.

READ MORE

Bio & Healthcare Tech Investments & Thesis | a16z (43)

Meet the Bio+Health Team

We’re former founders, operators, and entrepreneurs. We’re MDs, PhDs, scientists, and technologists. We bring the know-how and networks of five full operating teams and deep expertise from across our consumer, enterprise, and fintech practices to help founders find their edge.

We win as one team, and we win big.

See Full Team

Investing Team

  • Vijay Pande, PhD Investing
  • Julie Yoo Investing
  • Vineeta Agarwala, MD, PhD Investing
  • Jorge Conde Investing
  • Ben Horowitz Investing
  • Marc Andreessen Investing
  • Scott Kupor Investing
Annie Collins Investing
Becky Pferdehirt Investing
Ben Portney Investing
Bowen Liu Investing
Bryan Faust Investing
Caroline Goggins Investing
Daisy Wolf Investing
Jay Rughani Investing
Justin Larkin Investing
Zak Doric Investing

Operations

Adela Tomsejova Corporate Development
Alison Martin Operations
Alyssa Torres Operations
Amy Hoemeke Operations
Andrea Acedo Trueba Operations
Anna Jablonski Operations
Ashley Stern Operations
Beth Newman Full Stack Talent
Bob Badal Business Development
Ceia Font Operations
Chris Ham Full Stack Talent
Colin Rom Marketing
Ellen Tunoa Full Stack Talent
Emily Keir Operations
Erika Louie HR
Ginger Liau Business Development
James Watson Business Development
Jen Walsh Marketing
Jennifer Young Full Stack Talent
Kirstin Arbide Marketing
Kris Tatiossian Marketing
Maggie Romero Operations
Margaret Jen Marketing
Marina Kusserow Business Development
Michael Cialone Business Development
Olivia Webb Marketing
Pamon Forouhar Operations
Samantha Walter Business Development
Sarah Mascardo HR
Sheela Krothapalli People Practices
Sue Hager Marketing

Network Advisors

Dan Nomura Advisory Partner
Dan Rosenthal Advisory Partner
Greg Verdine Venture Partner
Julie Klapstein Advisory Partner
Margaret McKenna Advisory Partner
Surya Ganguli Venture Partner
Will Shrank Venture Partner

Bio & Healthcare Tech Investments & Thesis | a16z (156)

Want more
a16z Bio + Health?

Sign up for our bio + health newsletter to get the latest take from us on the future of biology, technology, and care delivery.

MANAGE MY SUBSCRIPTIONS By clicking the Subscribe button, you agree to the Privacy Policy.

Bio & Healthcare Tech Investments & Thesis | a16z (2024)

FAQs

Is Andreessen Horowitz a good firm? ›

Andreessen Horowitz has an employee rating of 4.2 out of 5 stars, based on 22 company reviews on Glassdoor which indicates that most employees have an excellent working experience there.

Who is the owner of a16z? ›

Andreessen Horowitz (also called a16z, legal name AH Capital Management, LLC) is a private American venture capital firm, founded in 2009 by Marc Andreessen and Ben Horowitz.

Why is a16z famous? ›

Andreessen Horowitz (a16z) is a major venture capital firm known for investing in some of the most inventive and successful firms of the twenty-first century.

What is the philosophy of a16z? ›

We have an optimistic view of the future and believe that entrepreneurs, whether they succeed or fail, are working to help us achieve a better future. As a result, we never publicly criticize any entrepreneur or startup (doing so is a fireable offense).

Does a16z pay well? ›

As of May 27, 2024, the average hourly pay for an A16Z in the United States is $28.00 an hour.

How much does a partner at Andreessen make? ›

Average Andreessen Horowitz Partner yearly pay in the United States is approximately $237,393, which is 219% above the national average.

How did Ben Horowitz make his money? ›

Ben is the co-founder of Andreessen Horowitz, one of the most influential venture capital firms in Silicon Valley. Prior to his VC career, he founded Opsware slash LoudCloud, which was acquired by Hewlett Packard for $1.6 billion.

How did Andreessen Horowitz make his money? ›

Andreessen runs influential Silicon Valley venture capital firm Andreessen Horowitz, whose successful bets include Instagram, Oculus VR and GitHub. His first claim to fame was cofounding web browser firm Netscape, which AOL bought in 1998 for $4.2 billion in stock.

How many employees does Andreessen Horowitz have? ›

As of May 2024, Andreessen Horowitz has approximately 672 employees across 6 continents, including North AmericaEuropeAsia. Key team members include Chief Operating Officer, Growth Fund: S. D. Partner Ceo: F. L. Partner, Principal - Talent: J. D..

Is a16z successful? ›

Andreessen Horowitz, also known as a16z, was established in 2009 and is now one of the most prominent investment companies globally. According to the company's reports, it manages assets amounting to $42 billion across 28 funds.

What is the minimum investment in Andreessen Horowitz? ›

Andreessen Horowitz Fund VIII General Information

The fund is located in Menlo Park, California. The fund will invest minimum USD 0.025 million in each company.

Where did Marc Andreessen make his money? ›

Marc co-created the highly influential Mosaic internet browser and co-founded Netscape, which later sold to AOL for $4.2 billion. He also co-founded Loudcloud, which as Opsware, sold to Hewlett-Packard for $1.6 billion. He later served on the board of Hewlett-Packard from 2008 to 2018.

How much is Marc Andreessen worth? ›

Did a16z invest in Facebook? ›

As of my knowledge cut-off in 2021, Marc Andreessen is an investor and board member of Facebook. He co-founded the venture capital firm Andreessen Horowitz, which has invested in a number of tech companies, including Facebook.

What is the mission statement of a16z? ›

We aim to connect entrepreneurs, investors, executives, engineers, academics, industry experts, cultural geniuses, and others in the technology ecosystem.

What is the most successful VC firm? ›

Top Venture Capital Firms
  1. Sequoia Capital. Sequoia is one of the most well-known VC firms in the world. ...
  2. Andreessen Horowitz. ...
  3. Kleiner Perkins. ...
  4. Insight Partners. ...
  5. Tiger Global Management. ...
  6. New Enterprise Associates. ...
  7. Khosla Ventures. ...
  8. Norwest Venture Partners.
Mar 12, 2024

What are Andreessen Horowitz management fees? ›

That translates into huge management fees—the annual dues that limited partners pay venture capitalists just to invest their money, regardless of performance. On one of the firm's latest crypto funds, Andreessen Horowitz commanded a 2.5% fee, which would mean receiving $50 million a year on a $2 billion fund.

What is a16z biggest check? ›

Adam Neumann's startup received $350 million from the tech kingmaker A16z, its biggest check ever. His residential startup is now valued at $1 billion. He bought $1 billion in apartments last year. Early in 2022, A16z led funding for Neumann's climate crypto startup FlowCarbon, which is in limbo.

Top Articles
Latest Posts
Article information

Author: Ray Christiansen

Last Updated:

Views: 5679

Rating: 4.9 / 5 (49 voted)

Reviews: 80% of readers found this page helpful

Author information

Name: Ray Christiansen

Birthday: 1998-05-04

Address: Apt. 814 34339 Sauer Islands, Hirtheville, GA 02446-8771

Phone: +337636892828

Job: Lead Hospitality Designer

Hobby: Urban exploration, Tai chi, Lockpicking, Fashion, Gunsmithing, Pottery, Geocaching

Introduction: My name is Ray Christiansen, I am a fair, good, cute, gentle, vast, glamorous, excited person who loves writing and wants to share my knowledge and understanding with you.